Healthequity Stock Performance

HQY Stock  USD 79.72  0.24  0.30%   
On a scale of 0 to 100, HealthEquity holds a performance score of 15. The company retains a Market Volatility (i.e., Beta) of 0.68, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, HealthEquity's returns are expected to increase less than the market. However, during the bear market, the loss of holding HealthEquity is expected to be smaller as well. Please check HealthEquity's value at risk, and the relationship between the standard deviation and kurtosis , to make a quick decision on whether HealthEquity's current trending patterns will revert.

Risk-Adjusted Performance

15 of 100

 
Low
 
High
Good
Compared to the overall equity markets, risk-adjusted returns on investments in HealthEquity are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, HealthEquity showed solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
0.3
Five Day Return
(3.77)
Year To Date Return
20.48
Ten Year Return
352.95
All Time Return
352.95
1
Heres Why Investors Should Retain Thermo Fisher Stock
01/17/2024
2
HealthEquity, Inc. Shares Purchased by Loomis Sayles Co. L P - MarketBeat
02/16/2024
3
Why HealthEquity is a Top Momentum Stock for the Long-Term
03/01/2024
4
HealthEquity Reports Next Week Wall Street Expects Earnings Growth
03/12/2024
5
Should You Buy HealthEquity Ahead of Earnings
03/14/2024
6
Should You Be Confident in HealthEquity
03/15/2024
7
Heres Why HealthEquity is a Strong Momentum Stock
03/18/2024
8
HealthEquity Non-GAAP EPS of 0.63 beats by 0.03, revenue of 262.39M beats by 3.4M
03/19/2024
9
HealthEquity Q4 Earnings Surpass Estimates, Margins Up
03/20/2024
10
Disposition of 60000 shares by Jon Kessler of HealthEquity at 14.0 subject to Rule 16b-3
03/22/2024
11
HealthEquity CEO Kessler sells shares worth over 2.6m
03/26/2024
Begin Period Cash Flow254.3 M
  

HealthEquity Relative Risk vs. Return Landscape

If you would invest  6,630  in HealthEquity on December 29, 2023 and sell it today you would earn a total of  1,342  from holding HealthEquity or generate 20.24% return on investment over 90 days. HealthEquity is generating 0.3146% of daily returns assuming volatility of 1.5662% on return distribution over 90 days investment horizon. In other words, 13% of stocks are less volatile than HealthEquity, and above 94% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon HealthEquity is expected to generate 2.73 times more return on investment than the market. However, the company is 2.73 times more volatile than its market benchmark. It trades about 0.2 of its potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.23 per unit of risk.

HealthEquity Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for HealthEquity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HealthEquity, and traders can use it to determine the average amount a HealthEquity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.2009

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsHQY
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 1.57
  actual daily
13
87% of assets are more volatile

Expected Return

 0.31
  actual daily
6
94% of assets have higher returns

Risk-Adjusted Return

 0.2
  actual daily
15
85% of assets perform better
Based on monthly moving average HealthEquity is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HealthEquity by adding it to a well-diversified portfolio.

HealthEquity Fundamentals Growth

HealthEquity Stock prices reflect investors' perceptions of the future prospects and financial health of HealthEquity, and HealthEquity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HealthEquity Stock performance.

About HealthEquity Performance

To evaluate HealthEquity Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when HealthEquity generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare HealthEquity Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand HealthEquity market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents HealthEquity's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Return On Capital Employed 0.04  0.04 
Return On Assets 0.02  0.02 
Return On Equity 0.03  0.03 

Things to note about HealthEquity performance evaluation

Checking the ongoing alerts about HealthEquity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HealthEquity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 98.0% of the company shares are owned by institutional investors
Latest headline from investing.com: HealthEquity CEO Kessler sells shares worth over 2.6m
Evaluating HealthEquity's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate HealthEquity's stock performance include:
  • Analyzing HealthEquity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HealthEquity's stock is overvalued or undervalued compared to its peers.
  • Examining HealthEquity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating HealthEquity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HealthEquity's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of HealthEquity's stock. These opinions can provide insight into HealthEquity's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating HealthEquity's stock performance is not an exact science, and many factors can impact HealthEquity's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.
For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for HealthEquity Stock analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.96)
Earnings Share
0.64
Revenue Per Share
11.682
Quarterly Revenue Growth
0.122
Return On Assets
0.0256
The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.